Antibacterial Mode of Action of Ib-AMP1 Against Escherichia coli O157:H7

Probiotics and Antimicrobial Proteins

Volumn 5, Issue 2, 2013, Pages 131-141

  Wu, Wen Hsuan ^a   Di, Rong ^a   Matthews, Karl R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Antimicrobial peptide; E. coli O157:H7; Ib AMP1; Mode of action

Indexed keywords

ADENOSINE TRIPHOSPHATE; IB AMP1; POLYPEPTIDE ANTIBIOTIC AGENT; POTASSIUM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; ESCHERICHIA COLI O157; IMPATIENS; IN VIVO STUDY; MACROMOLECULE; NONHUMAN; PLANT SEED; POROSITY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS;

ESCHERICHIA COLI; IMPATIENS BALSAMINA;

EID: 84877600918     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-013-9127-1     Document Type: Article

References (49)

1. Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM (2011) Foodborne illness acquired in the United States- unspecified agents. Emerg Ingect Dis 17(1): 16-22.
2. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, Jones JL, Griffin PM (2011) Foodborne illness acquired in the United States- mojor pathogens. Emerg Infect Dis 17(1): 7-15.
3. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV (1999) Food-related illness and death in the United States. Emerg Infect Dis 5(5): 607-625.
4. BC center for disease control (2009) Writing your own food safety plan- the HACCP way-a guide for food service operations. http://www. bccdc. ca/foodhealth/foodguidelines/default. htm. Accessed 7 November 2012.
5. Meng J, Zhao S, Doyle MP, Joseph SW (1998) Antibiotic resistance of Escherichia coli O157: H7 and O157: NM isolated from animals, foods, and humans. J Food Prot 61(11): 1511-1514.
6. Musgrove MT, Jones DR, Northcutt JK, Cox NA, Harrison MA, Fedorka-Cray PJ, Ladely SR (2006) Antimicrobial resistance in Salmonella and Escherichia coli isolated from commercial shell eggs. Poult Sci 85(9): 1665-1669.
7. Ganz T, Lehrer RI (1998) Antimicrobial peptides of vertebrates. Curr Opin Immunol 10(1): 41-44.
8. García-Olmedo F, Molina A, Alamillo JM, Rodríguez-Palenzuéla P (1998) Plant defense peptides. Biopolymers 47(6): 479-491.
9. Bulet P, Hetru C, Dimarcq JL, Hoffmann D (1999) Antimicrobial peptides in insects; structure and function. Dev Comp Immunol 23(4-5): 329-344.
10. van't Hof W, Veerman EC, Helmerhorst EJ, Amerongen AV (2001) Antimicrobial peptides: properties and application. Biol Chem 382(4): 597-619.
11. Hammami R, Ben Hamida J, Vergoten G, Fliss I (2009) PhytAMP: a database dedicated to antimicrobial plant peptides. Nucleic Acids Res 37(1): D963-D968.
12. Barbosa Pelegrini P, Del Sarto RP, Silva ON, Franco OL, Grossi-de-Sa MF (2011) Antimicrobial peptides from plants: what they are and how they probably work. Biochem Res Int 2011: 250349.
13. Thomma BP, Cammue BP, Thevissen K (2002) Plant defensins. Planta 216(2): 193-202.
14. Lay FT, Anderson MA (2005) Defensins: components of the innate immune system in plants. Curr Protein Pept Sci 6(1): 85-101.
15. Cândido ES, Porto WF, Amaro DA, Viana JC, Dias SC, Franco OL (2011) Structural and functional insights into plant bactericidal peptides. In: Mendez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances, vol. 2. Spain: Formatex Research Center, pp. 951-960. ISBN (13): 978-84-939843-2-8.
16. Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF (1997) A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein. J Biol Chem 272(39): 24480-24487.
17. Wang P, Bang JK, Kim HJ, Kim JK, Kim Y, Shin SY (2009) Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1. Peptides 30(12): 2144-2149.
18. Patel SU, Osborn R, Rees S, Thornton JM (1998) Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1). Biochemistry 37(4): 983-990.
19. Lee DG, Shin SY, Kim DH, Seo MY, Kang JH, Lee Y, Kim KL, Hahm KS (1999) Antifungal mechanism of a cystein-rich antimicrobial peptide, Ib-AMP1, from Impatiens balsamina against Candida albicans. Biotechnol Lett 22(12): 1047-1050.
20. Thevissen K, Francois IE, Sijtsma L, van Amerongen A, Schaaper WM, Meloen R, Posthuma-Trumpie T, Broekaert WF, Cammue BP (2005) Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4. Peptides 26(7): 1113-1119.
21. Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788(8): 1687-1692.
22. Matsuzaki K, Sugishita K, Fujii N, Miyajima K (1995) Molecular basis for membrane selectivity of an antimicrobial peptide, Magainin 2. Biochemistry 34(10): 3423-3429.
23. Epand RM, Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462(1-2): 11-28.
24. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial action and resistance. Pharmacol Rev 55(1): 27-55.
25. Cudic M, Otvos L Jr (2002) Intracellular targets if antibacterial peptides. Curr Drug Targets 3(2): 101-106.
26. Mead PS, Griffin PM (1998) Escherichia coli O157: H7. Lancet 352(9135): 1207-1212.
27. Orlov DS, Nguyen T, Lehrer RI (2002) Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods 49(3): 325-328.
28. Yasuda K, Ohmizo C, Katsu T (2003) Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes. J Microbiol Methods 54(1): 111-115.
29. Murdock C, Chikindas ML, Matthews KR (2010) The pepsin hydrolysate of bovine lactoferrin causes a collapse of the membrane potential in Escherichia coli O157: H7. Probiotics Antimicro Prot 2(2): 112-119.
30. Suzuki M, Yamamoto T, Kawai Y, Inoue N, Yamazaki K (2005) Mode of action of piscicocin CS526 produced by Carnobacterium pisicola CS526. J Appl Microbiol 98: 1146-1151.
31. Breeuwer P, Abee T (2004) Assessment of the membrane potential, intracellular pH and respiration of bacterial employing fluorescence techniques. In: Kowalchuck GA, de Brulin FJ, Head IM, Akkermans AD, van Elsas JD (eds) Molecular microbial ecology manual, 2nd edn. Kluwer Academic Publishers, Netherlands, pp 1563-1580.
32. Loh B, Grant C, Hancock RE (1984) Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26(4): 546-551.
33. Cotsonas King A, Wu L (2009) Macromolecular synthesis and membrane perturbation assays for mechanisms of action studies of antimicrobial agents. Curr Protoc Pharmacol Chapter 13: 13A. 7. 1-13A. 7. 23.
34. Xiong YQ, Bayer AS, Yeaman MR (2002) Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal protein. J Infect Dis 185(3): 348-356.
35. McEntire JC, Carman GM, Montville TJ (2004) Increased ATPase activity is responsible for acid sensitivity of nisin-resistant Listeria monocytogenes ATCC 700302. Appl Environ Microbiol 70(5): 2717-2721.
36. Guihard G, Bénédetti H, Besnard M, Letellier L (1993) Phosphate efflux through the channels formed by colicins and phage T5 in Escherichia coli cells is responsible for the fall in cytoplasmic ATP. J Biol Chem 268(24): 17775-17780.
37. Ultee A, Kets EPW, Smid EJ (1999) Mechanisms of action of carvacrol on the foodborne pathogen Bacillus cereus. Appl Environ Microbiol 65(10): 4606-4610.
38. Pol IE, Krommer J, Smid EJ (2002) Bioenergistic consequences of nisin combined with carvacrol towards Bacillus cereus. Innov Food Sci Emerg Technol 3(1): 55-61.
39. Hilpert K, McLeod B, Yu J, Elliott MR, Rautenbach M, Ruden S, Burck J, Muhle-Goll C, Ulrich AS, Keller S, Hancock REW (2010) Short cationic antimicrobial peptides interact with ATP. Antimicrob Agents Chemother 54(10): 4480-4483.
40. Stephan J, Mailaender EtienneG, Daffé M, Niederweis M (2004) Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother 48(11): 4163-4170.
41. Kotera Y, Inoue M, Mitsuhashi S (1990) Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhirium. Antimicrob Agents Chemother 34(7): 1323-1325.
42. Nikaido K, Nakae T (1979) The outer membrane of gram-negative bacteria. Adv Microb Physiol 20: 163-250.
43. Hancock RE, Raffle VJ, Nicas TI (1981) Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 19(5): 777-785.
44. Hancock RE, Wong PG (1984) Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. Antimicrob Agents Chemother 26(1): 48-52.
45. Helander IM, Nurmiaho-Lassila EL, Ahvenainen R, Rhoades J, Roller S (2001) Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria. Int J Food Microbiol 71(2-3): 235-244.
46. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM (2000) Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol 66(5): 2001-2005.
47. Leive L (1965) Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun 21(4): 290-296.
48. Leive L (1974) The barrier function of gram-negative envelop. Ann N Y Acad Sci 235: 109-129.
49. Hukari R, Helander IM, Vaara M (1986) Chain length heterogeneity of lipopolysaccharide released from Salmonella typhimurium by ethylenediaminetetraacetic acid or polycations. Eur J Biochem 154(3): 673-676.